State of New Jersey Common Pension Fund D Boosts Holdings in ICU Medical, Inc. (NASDAQ:ICUI)

State of New Jersey Common Pension Fund D boosted its position in shares of ICU Medical, Inc. (NASDAQ:ICUI) by 1.6% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 12,370 shares of the medical instruments supplier’s stock after purchasing an additional 191 shares during the quarter. State of New Jersey Common Pension Fund D owned about 0.05% of ICU Medical worth $1,919,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. New York State Teachers Retirement System increased its holdings in ICU Medical by 6.7% in the 4th quarter. New York State Teachers Retirement System now owns 28,343 shares of the medical instruments supplier’s stock worth $4,398,000 after buying an additional 1,777 shares in the last quarter. Equitable Trust Co. boosted its holdings in shares of ICU Medical by 1.6% during the 4th quarter. Equitable Trust Co. now owns 5,297 shares of the medical instruments supplier’s stock valued at $822,000 after acquiring an additional 84 shares during the last quarter. Jennison Associates LLC bought a new stake in shares of ICU Medical in the fourth quarter worth approximately $556,000. Gagnon Securities LLC raised its holdings in shares of ICU Medical by 0.5% during the fourth quarter. Gagnon Securities LLC now owns 28,881 shares of the medical instruments supplier’s stock valued at $4,481,000 after purchasing an additional 137 shares during the last quarter. Finally, OLD National Bancorp IN raised its holdings in shares of ICU Medical by 22.0% during the fourth quarter. OLD National Bancorp IN now owns 1,462 shares of the medical instruments supplier’s stock valued at $227,000 after purchasing an additional 264 shares during the last quarter. 96.10% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, CEO Vivek Jain sold 1,373 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares in the company, valued at approximately $16,262,119.64. The trade was a 1.30 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director David C. Greenberg sold 972 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $158.11, for a total transaction of $153,682.92. Following the completion of the transaction, the director now directly owns 5,037 shares of the company’s stock, valued at $796,400.07. This trade represents a 16.18 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 15,775 shares of company stock worth $2,548,017 over the last quarter. Company insiders own 6.70% of the company’s stock.

ICU Medical Trading Up 1.9 %

ICUI stock opened at $160.25 on Tuesday. ICU Medical, Inc. has a twelve month low of $93.36 and a twelve month high of $196.26. The stock has a market capitalization of $3.92 billion, a price-to-earnings ratio of -35.07 and a beta of 0.63. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The firm’s fifty day simple moving average is $160.76 and its two-hundred day simple moving average is $166.28.

Analyst Upgrades and Downgrades

Several brokerages recently commented on ICUI. StockNews.com raised ICU Medical from a “hold” rating to a “buy” rating in a report on Wednesday, November 20th. Jefferies Financial Group raised ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 target price on the stock in a research report on Wednesday, December 11th. Needham & Company LLC reaffirmed a “hold” rating on shares of ICU Medical in a research report on Wednesday, November 13th. Finally, KeyCorp increased their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 13th. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat, ICU Medical presently has a consensus rating of “Moderate Buy” and an average target price of $199.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.